IP Library › Granted Patent US 12,478,258
Granted Patent B2
US 12,478,258 · App. 18/179,302 · Granted Nov 25, 2025

Blood glucose estimation using near infrared light emitting diodes

Inventors: Bruce Matichuk (Alberta, CA); Mike E. Moore (Las Vegas, NV)
Assignee: MedWatch Technologies, Inc.
A61B5/0075A61B5/683A61B5/7278A61B5/742A61B2562/0233
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,478,258
App. No.
18/179,302
Granted
Nov 25, 2025
Kind
B2
Abstract

Near Infrared Spectroscopy is employed to non-invasively detect blood glucose concentrations, in a multi-sensing detection device. A multi-layered artificial neural network is used to assess these relationships of non-linear interference from human tissue, as well as differences among individuals, and accurately estimate blood glucose levels. Diffuse reflectance spectrum from the palm at six different wavelengths analyzed with a neural network, results in a correlation coefficient as high as 0.9216 when compared to a standard electrochemical glucose analysis test.

Claims (40)

1 . A continuous non-invasive sensor system having a multi-sensing detection device, the sensor system for employing spectral related skin response data for determining a light signature from which a concentration of glucose being present in a tissue of a body of a wearer of the multi-sensing detection device may be determined, the system comprising:

a multi-sensing detection device being configured for being positioned proximate the skin when the multi-sensing detection device is coupled to the body of the wearer, the multi-sensing detection device having a glucose sensor unit for detecting glucose being present within the wearer's tissue, the multi-sensing detection device comprising:

a housing configured so as to be positionable proximate the skin of the wearer, the housing further being configured for encasing the glucose sensor unit, the housing having a top cover and a bottom cover;

a glucose sensor unit for detecting a skin characteristic response of one or more tissues of the body due to a presence of glucose within the tissue, the glucose sensor unit comprising:

a printed circuit board having a first and a second sensor array coupled therewith, each sensor array including a number of photoemitters and one or more photoreceivers, each sensor array being arranged on the printed circuit board within in the housing so as to be proximate the user's tissue when the multi-sensing detection device is coupled to the user's body, the one or more photoemitters configured to illuminate, in one or more cycles, at a predetermined frequency and duration of light, the tissue of the user's body, and each of the one more photoreceivers configured to receive a return of the light reflected back from the user's tissue and to generate a return signal in response to collecting the reflected light,

the first sensor array comprising six photoemitters positioned so as to be proximate at least a first photoreceiver and being configured for directing light so as to penetrate a determined depth within the tissue of the user's body, the six photoemitters including a first photoemitter formed of a first light emitting diode configured for emitting light of a first wavelength, a second photoemitter formed of a second light emitting diode configured for emitting light of a second wavelength, a third photoemitter formed of a third light emitting diode configured for emitting light of a third wavelength, a fourth photoemitter formed of a fourth light emitting diode configured for emitting light of a fourth, a fifth photoemitter formed of a fifth light emitting diode configured for emitting light of a fifth wavelength, and a sixth photoemitter formed of a sixth light emitting diode configured for emitting light of a sixth wavelength, wherein the first photoreceiver is configured for detecting light of the six photoemitters reflected back from the body's tissues, and

the second sensor array comprising a number of additional photoemitters positioned so as to be proximate at least a second photoreceiver, wherein the second photoreceiver is configured for detecting light of the number of additional photoemitters reflected back from the body's tissues, collectively the light emitting diodes of the first and second sensory array being configured for directing the emitted light of their respective wavelengths into the tissue of the wearer, and the at least first and second photoreceivers being configured for collecting the light reflected back form the body tissue so as to generate the return signal,

the printed circuit board further comprising an analog to digital converter coupled to the at least first and second photoreceivers, the analog to digital converter being configured for converting the return signal to digital signal data, and a communications module for transmitting the digital signal data; and

a server system for receiving the digital signal data from the multi-sensing detection device, the server system comprising a first processing module having a first processor for analyzing the digital signal data so as to produce light signature data, and a second processor for analyzing the light signature data so as to thereby determine the concentration of glucose being present in the tissue of the body of the wearer.

2 . The continuous non-invasive sensor system in accordance with claim 1 , wherein the second array comprises four photoemitters positioned so as to be proximate the second photoreceiver, the four photoemitters including a seventh photoemitter formed of a seventh light emitting diode configured for emitting light of a seventh wavelength, an eighth photoemitter formed of a eighth light emitting diode configured for emitting light of an eighth wavelength, a ninth photoemitter formed of a ninth light emitting diode configured for emitting light of a ninth wavelength, and a tenth photoemitter formed of a tenth light emitting diode configured for emitting light of a tenth wavelength.

3 . The continuous non-invasive sensor system in accordance with claim 2 , wherein the seventh light emitting diode is configured for emitting light of a wavelength of about 450 nm, the eighth light emitting diode is configured for emitting light of a wavelength of about 650 nm, the ninth light emitting diode is configured for emitting light of a wavelength of about 750 nm, and the tenth light emitting diode is configured for emitting light of a wavelength of about 950 nm, wherein the second photoreceiver is configured for detecting light of the four photoemitters reflected back from the body's tissues.

4 . The continuous non-invasive sensor system in accordance with claim 1 , wherein the second array comprises three photoemitters positioned so as to be proximate the second photoreceiver, the three photoemitters including a seventh photoemitter formed of a seventh light emitting diode configured for emitting light of a seventh wavelength, an eighth photoemitter formed of a eighth light emitting diode configured for emitting light of an eighth wavelength, and a ninth photoemitter formed of a ninth light emitting diode configured for emitting light of a ninth wavelength.

5 . The continuous non-invasive sensor system in accordance with claim 4 , wherein the seventh photoemitter is configured for emitting red light, the eighth photoemitter is configured for emitting green light, and the ninth photoemitter is configured for emitting infrared light.

6 . The continuous non-invasive sensor system in accordance with claim 5 , wherein the second sensor array comprises a PPG sensor assembly.

7 . The continuous non-invasive sensor system in accordance with claim 6 , wherein the printed circuit board comprises one or more of an accelerometer and an SPO2 assembly.

8 . The continuous non-invasive sensor system in accordance with claim 7 , wherein the printed circuit board additionally comprises an ECG module and a plurality of ECG electrodes, at least one of the plurality of ECG electrodes being a ground ECG electrode, the ground ECG electrode being positioned on opposite sides of the first and second sensor array.

9 . The continuous non-invasive sensor system in accordance with claim 6 , wherein the server system comprises an Artificial Intelligence module, and the Artificial Intelligence module is configured for receiving and analyzing the digital signal data so as to produce the light signature results data.

10 . The continuous non-invasive sensor system in accordance with claim 9 , wherein the Artificial Intelligence module comprises a Machine Learning module and an Artificial Neural Network (ANN).

11 . The continuous non-invasive sensor system in accordance with claim 10 , wherein the ANN maps the light signature results data to the concentration of glucose.

12 . The continuous non-invasive sensor system in accordance with claim 11 , wherein the mapping comprises comparing an intensity of a number of reflected light wavelengths to the absorption response of the skin so as to determine the light signature, whereby a level of concentration of glucose can be determined by the light signature based on a change in a pattern of the skin's absorption response caused by the presence of glucose within the skin.

13 . The continuous non-invasive sensor system in accordance with claim 12 , wherein the determining of the absorption response is based on a non-linear relationship between changes of reflectance due to a range of different wavelengths.

14 . The continuous non-invasive sensor system in accordance with claim 13 , wherein the ANN is further configured for determining a health trajectory of the wearer, from which health trajectory a future health state of the wearer is predicted.

15 . A continuous non-invasive sensor system having a multi-sensing detection device, the sensor system for employing diffuse reflectance spectrum analysis for determining a skin response from which a concentration of an analyte being present in a skin tissue of a body of a wearer of the multi-sensing detection device may be determined, the system comprising:

an attachment structure having an inner portion and an outer portion, the inner portion for engaging with the multi-sensing detection device, and the outer portion including a surface having an adhesive so as to hold the attachment structure against the wearer's skin; and

a multi-sensing detection device retained within the inner portion of the attachment structure and being configured for being positioned proximate the skin of the wearer when the attachment structure is adhered to the body of the wearer, the multi-sensing detection device having an analyte sensor unit for detecting a specific analyte being present within the wearer's tissue, the multi-sensing detection device comprising:

a housing configured for engaging with the attachment structure in a manner so as to be held against the body of the wearer, the housing further being configured for encasing the analyte sensor unit, the housing having a top cover and a bottom cover, the bottom cover including a transparent portion therein;

an analyte sensor unit for detecting a characteristic skin response of one or more tissues of the body due to a presence of the analyte within the tissue, the analyte sensor unit comprising:

a printed circuit board having a first and a second sensor array coupled therewith, each sensor array including a number of photoemitters and one or more photoreceivers, each sensor array being arranged on the printed circuit board within the housing proximate the transparent portion opposite the user's tissue, the one or more photoemitters configured to illuminate, in a plurality of cycles, at a predetermined frequency and duration of light, the user's tissue, and each of the one more photoreceivers configured to receive a return of the light reflected back from the user's tissue and to generate a return signal in response to collecting the reflected light,

the first sensor array comprising six photoemitters positioned proximate at least a first photoreceiver, the six photoemitters including a first photoemitter formed of a first light emitting diode configured for emitting light of a wavelength of about 1050 nm, a second photoemitter formed of a second light emitting diode configured for emitting light of a wavelength of about 1200 nm, a third photoemitter formed of a third light emitting diode configured for emitting light of a wavelength of about 1300 nm, a fourth photoemitter formed of a fourth light emitting diode configured for emitting light of a wavelength of about 1450 nm, a fifth photoemitter formed of a fifth light emitting diode configured for emitting light of a wavelength of about 1550 nm, and a sixth photoemitter formed of a sixth light emitting diode configured for emitting light of a wavelength of about 1650 nm, wherein the first photoreceiver is configured for detecting light of the six photoemitters reflected back from the body's tissues, and

the second array comprising three photoemitters positioned so as to be proximate a second photoreceiver, the three photoemitters including a seventh photoemitter formed of a seventh light emitting diode configured for emitting light of a seventh wavelength, an eighth photoemitter formed of a eighth light emitting diode configured for emitting light of an eighth wavelength, and a ninth photoemitter formed of a ninth light emitting diode configured for emitting light of a ninth wavelength,

wherein the second photoreceiver is configured for detecting light of the three photoemitters reflected back from the body's tissues, and further wherein, collectively, the light emitting diodes of the first and second sensory arrays are configured for directing the emitted light of their respective wavelengths into the tissue of the wearer, and the plurality of photoreceivers are configured for collecting the light reflected back form the body tissue so as to generate the return signal;

the printed circuit board further comprising an analog to digital converter coupled to the at least first and second photoreceivers, the analog to digital converter being configured for converting the return signal to digital signal data, and a communications module for transmitting the digital signal data; and

a control unit coupled to the printed circuit board, the control unit configured to generate activation of each of the photoemitters, whereby each photoemitter of the first and second sensor arrays may be activated individually or collectively in one or more of a predetermined wavelength, a predetermined frequency, a predetermined intensity, and a predetermined duration.

16 . The continuous non-invasive sensor system in accordance with claim 15 , further comprising a server system for receiving the digital signal data from the multi-sensing detection device, the server system comprising a first processing module having a first processor for analyzing the digital signal data so as to produce spectral array data, and a second processor for analyzing the spectral array data so as to thereby determine a light signature of the skin in response to receipt of the spectral array of light waves from which light signature the concentration of the analyte being present in the skin tissue of the body of the wearer.

17 . The continuous non-invasive sensor system in accordance with claim 16 , wherein the activation of the photoemitters in accordance with the predetermined wavelength, frequency, intensity, and/or duration results in a pattern of absorption, and the second processor employs the pattern of absorption in determining the light signature from which the concentration of the analyte being present in the tissue of the body of the wearer.

18 . The continuous non-invasive sensor system in accordance with claim 17 , wherein the seventh light emitting diode is configured for emitting red light, the eighth light emitting diode is configured for emitting green light, and the ninth light emitting diode is configured for emitting infrared light.

19 . The continuous non-invasive sensor system in accordance with claim 18 , wherein the second sensor array comprises a PPG sensor assembly.

20 . The continuous non-invasive sensor system in accordance with claim 19 , wherein the server system further comprises an Artificial Intelligence module, and the Artificial Intelligence module is configured for receiving and analyzing the digital signal data so as to produce the light signature results data.

21 . The continuous non-invasive sensor system in accordance with claim 20 , wherein the Artificial Intelligence module comprises a Machine Learning module and an Artificial Neural Network (ANN), and further wherein the ANN maps the light signature results data to the concentration of the analyte.

22 . The continuous non-invasive sensor system in accordance with claim 21 , wherein the mapping comprises comparing an intensity of a number of reflected light wavelengths to the pattern of absorption of the skin so as to determine the light signature, whereby a level of concentration of glucose can be determined by the light signature based on a change in the skin's absorbance response caused by the presence of glucose within the skin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2023
From: MATICHUK, BRUCE; MOORE, MIKE E.
To: MEDWATCH TECHNOLOGIES, INC.
Reel/Frame 062897/0211 →
Continuity (2)
Provisional Application 63316901 · Mar 4, 2022
Related Publication 20230284905A1 · Sep 14, 2023
References Cited (98)
US 9420956B2 · Gopalakrishnan et al. · 2016 [cited by applicant]
US 9554738B1 · Gulati et al. · 2017 [cited by applicant]
US 9582072B2 · Connor · 2017 [cited by applicant]
US 9750977B2 · Yuen et al. · 2017 [cited by applicant]
US 9826940B1 · Lengerich · 2017 [cited by applicant]
US 10153537B2 · Baringer et al. · 2018 [cited by applicant]
US 10321873B2 · Connor · 2019 [cited by applicant]
US 10327674B2 · Hong et al. · 2019 [cited by applicant]
US 10512407B2 · Richards et al. · 2019 [cited by applicant]
US 10700774B2 · Panther et al. · 2020 [cited by applicant]
US 10878959B1 · Reykhert · 2020 [cited by examiner]
US 10880724B2 · Song et al. · 2020 [cited by applicant]
US 10998101B1 · Tran et al. · 2021 [cited by applicant]
US 11029199B2 · Turgeon et al. · 2021 [cited by applicant]
US 11096601B2 · Hong et al. · 2021 [cited by applicant]
US 11116448B1 · Trapero Martin et al. · 2021 [cited by applicant]
US 11141129B1 · Trapero Martin et al. · 2021 [cited by applicant]
US 11166635B2 · Trapero Martin et al. · 2021 [cited by applicant]
US 11207025B1 · Trapero Martin et al. · 2021 [cited by applicant]
US 11357426B2 · Tran · 2022 [cited by applicant]
US 11694533B2 · Shelton, IV et al. · 2023 [cited by applicant]
US 11754542B2 · Connor · 2023 [cited by applicant]
US 11766216B2 · Zilkie et al. · 2023 [cited by applicant]
US 11786251B2 · Shelton, IV et al. · 2023 [cited by applicant]
US 11806109B2 · Yuen et al. · 2023 [cited by applicant]
US 20150119725A1 · Martin et al. · 2015 [cited by applicant]
US 20150320588A1 · Connor · 2015 [cited by applicant]
US 20160073886A1 · Connor · 2016 [cited by applicant]
US 20160081552A1 · Wojtczuk · 2016 [cited by examiner]
US 20160113526A1 · Nageshwar et al. · 2016 [cited by applicant]
US 20160232811A9 · Connor · 2016 [cited by applicant]
US 20160287110A1 · Morris et al. · 2016 [cited by applicant]
US 20160378069A1 · Rothkopf · 2016 [cited by examiner]
US 20170119287A1 · Flitsch et al. · 2017 [cited by applicant]
US 20170156676A1 · Ferber et al. · 2017 [cited by applicant]
US 20170164878A1 · Connor · 2017 [cited by applicant]
US 20170188864A1 · Drury · 2017 [cited by applicant]
US 20170215793A1 · Newberry · 2017 [cited by applicant]
US 20180146870A1 · Shemesh · 2018 [cited by examiner]
US 20180242860A1 · LeBoeuf et al. · 2018 [cited by applicant]
US 20180353137A1 · Balajadia et al. · 2018 [cited by applicant]
US 20190030230A1 · Connor · 2019 [cited by applicant]
US 20190110751A1 · Lee et al. · 2019 [cited by applicant]
US 20190246963A1 · Chung et al. · 2019 [cited by applicant]
US 20190283247A1 · Chang et al. · 2019 [cited by applicant]
US 20190385708A1 · Hong et al. · 2019 [cited by applicant]
US 20200075812A1 · Konstantatos et al. · 2020 [cited by applicant]
US 20200376198A1 · Newberry · 2020 [cited by examiner]
US 20210145334A1 · Ferber · 2021 [cited by examiner]
US 20210169345A1 · Wasson et al. · 2021 [cited by applicant]
US 20210169417A1 · Burton · 2021 [cited by applicant]
US 20210212606A1 · Tran · 2021 [cited by applicant]
US 20210293616A1 · Capella et al. · 2021 [cited by applicant]
US 20210321942A1 · Pushpala et al. · 2021 [cited by applicant]
US 20210330207A1 · Richards · 2021 [cited by examiner]
US 20210379388A1 · Connor · 2021 [cited by applicant]
US 20220028553A1 · Matichuk et al. · 2022 [cited by applicant]
US 20220233102A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220233119A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220233135A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220233136A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220233151A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220233191A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220233214A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220233241A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220233252A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220233253A1 · Shelton, VI et al. · 2022 [cited by applicant]
US 20220233254A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220233267A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220238197A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220238216A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220238235A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220240869A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220241028A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220241474A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220415476A1 · Connor · 2022 [cited by applicant]
US 20230103445A1 · Lee et al. · 2023 [cited by applicant]
US 20230284905A1 · Matichuk et al. · 2023 [cited by applicant]
US 20230355145A1 · Matichuk et al. · 2023 [cited by applicant]
US 20230400327A1 · Streem et al. · 2023 [cited by applicant]
US 20250049324A1 · Matichuk et al. · 2025 [cited by applicant]
US 20250082234A1 · Matichuk et al. · 2025 [cited by applicant]
AU 2023229292A1 · 2024 [cited by applicant]
AU 2023269185A1 · 2024 [cited by applicant]
CN 108451513A · 2018 [cited by applicant]
CN 110167430A · 2019 [cited by applicant]
EP 3387989A1 · 2018 [cited by applicant]
EP 4486206A2 · 2025 [cited by applicant]
IN 201941006594A · 2020 [cited by applicant]
KR 102062646B1 · 2020 [cited by applicant]
KR 20220112327A · 2022 [cited by applicant]
WO 2020160058A1 · 2020 [cited by applicant]
WO 2022231132A1 · 2022 [cited by applicant]
WO 2023014653A1 · 2023 [cited by applicant]
WO 2023187686A1 · 2023 [cited by applicant]
WO 2023220082A1 · 2023 [cited by applicant]
WO 2024173947A1 · 2024 [cited by applicant]
International Search Report and Written Opinion, (ISRWO), Application No. PCT/US2024/016553, pp. 1-17, dated Jul. 12, 2024. [cited by applicant]